Both medications can complement each other under medical supervision
Semaglutide also works by slowing down movement of food through the stomach and curbing appetite, thereby causing weight loss
CrossRef Gut microbiota supportive dietary pattern associated with reduced MASLD risk mediated by metabolomic profiles: a prospective cohort study Dong-Run Li, Ke-Ru Li, Ying Wang, Jia-Qi Zheng, Wen-Rui Zheng, Bang-Quan Liu, Jia-Cheng Liu, Rui-Han Bao, Ting-Ting Gong, Qiu-Ju Sheng, Shan-Yan Gao, Qi-Jun Wu Nutrition Journal .2026;[Epub] CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America Claudia P
Conclusions MASLD is one of the pressing public health issues
Author contributions All authors contributed to conception and design, analysis and interpretation of the evidence, drafting of the manuscript, finalization of the manuscript, and the decision to submit to publication
However, whether GIPR or GCGR agonist exerts an independent effect remain unclear